Ileal mucosal oxygen consumption is decreased in endotoxemic rats but is restored toward normal by treatment with aminoguanidine

Critical Care Medicine

Volumn 27, Issue 11, 1999, Pages 2518-2524

  King, Carroll J ^a   Tytgat, Stefaan ^a   Delude, Russell L ^a   Fink, Mitchell P ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Aminoguanidine; Endotoxemia; Ileal mucosal oxygen; Inducible nitric oxide synthase; Lipopolysaccharide; Mitochondria; Nitric oxide; Nitric oxide synthase; Respiration, cellular; Sepsis

Indexed keywords

AMINOGUANIDINE; BUFFER; GLUCOSE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; ENZYME INHIBITION; ILEUM MUCOSA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; PRIORITY JOURNAL; SEPSIS;

EID: 0032760428     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199911000-00032     Document Type: Article

References (42)

1. 1. Lucking SE, Williams TM, Chaten FC, et al: Dependence of oxygen consumption on oxygen delivery in children with hyperdynamic septic shock and low oxygen extraction. Crit Care Med 1990; 18:1316-1319
2. 2. Tuchschmidt J, Fried J, Swinney R, et al: Early hemodynamic correlates of survival in patients with septic shock. Crit Care Med 1989; 17:719-723
3. 3. Astiz ME, Rackow EC, Falk JL, et al: Oxygen delivery and consumption in patients with hyperdynamic septic shock. Crit Care Med 1987; 15:26-28
4. 4. Kariman K, Burns SR: Regulation of tissue oxygen extraction is disturbed in adult respiratory distress syndrome. Am Rev Respir Dis 1985; 132:109-114
5. 5. Vincent JL, Roman A, Kahn RJ: Dobutamine administration in septic shock: Addition to a standard protocol. Crit Care Med 1990; 18: 689-693
6. 6. Mela L, Bacalzo LV Jr, Miller LD: Defective oxidative metabolism of rat liver mitochondria in hemorrhagic and endotoxin shock. Am J Physiol 1971; 220:571-577
7. 7. Tavakoli H, Mela L: Alterations of mitochondrial metabolism and protein concentrations in subacute septicemia. Infect Immun 1982; 38:536-541
8. 8. Kantrow SP, Taylor DE, Carraway MS, et al: Oxidative metabolism in rat hepatocytes and mitochondria during sepsis. Arch Biochem Biophys 1997; 345:278-288
9. 9. Simonson SG, Welty-Wolf K, Huang YT, et al: Altered mitochondrial redox responses in Gram negative septic shock in primates. Circ Shock 1994; 43:34-43
10. 10. Premaratne S, Masuda E, Nishida S, et al: Does intravenous glutamine prevent bacterial translocation in hemorrhagic shock? Shock 1994; 2:262-266
11. 11. Greer GG, Milazzo FH: Pseudomonas aeruginosa lipopolysaccharide: An uncoupler of mitochondrial oxidative phosphorylation. Can J Microbiol 1975; 21:877-883
12. 12. Fry DE, Silver BB, Rink RD, et al: Hepatic cellular hypoxia in murine peritonitis. Surgery 1979; 85:652-661
13. 13. Garrison RN, Ratcliffe DJ, Fry DE: Hepatocellular function and nutrient blood flow in experimental peritonitis. Surgery 1982; 92: 713-719
14. 14. VanderMeer TJ, Wang H, Fink MP: Endotoxemia causes ileal mucosal acidosis in the absence of mucosal hypoxia in a normodynamic porcine model of septic shock. Crit Care Med 1995; 23:1217-1226
15. 15. Unno N, Wang H, Menconi MJ, et al: Inhibition of inducible nitric oxide synthase ameliorates endotoxin-induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997; 113:1246-1257
16. 16. Tepperman BL, Brown JF, Whittle BJ: Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993; 265(2 Pt 1):G214-G218
17. 17. Cook HT, Bune AJ, Jansen AS, et al: Cellular localization of inducible nitric oxide synthase in experimental endotoxic shock in the rat. Clin Sci 1994; 87:179-186
18. 18. Griffiths MJ, Messent M, MacAllister RJ, et al: Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br J Pharmacol 1993; 110:963-968
19. 19. Bryk R, Wolff DJ: Mechanism of inducible nitric oxide synthase inactivation by amino-guanidine and L-N6-(1-iminoethyl)lysine. Biochemistry 1998; 37:4844-4852
20. 20. Morin MJ, Unno N, Hodin RA, et al: Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 1998; 26: 1258-1264
21. 21. Khwaja A, Rodriguez-Viciana P, Wennstrom S, et al: Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J 1997; 16:2783-2793
22. 22. Strocchi A, Corazza G, Furne J, et al: Measurements of the jejunal unstirred layer in normal subjects and patients with celiac disease. Am J Physiol 1996; 270(3 Pt 1): G487-G491
23. 23. Levitt MD, Furne JK, Levitt DG: Shaking of the intact rat and intestinal angulation diminish the jejunal unstirred layer. Gastroenterology 1992; 103:1460-1466
24. 24. Hotchkiss RS, Swanson PE, Cobb JP, et al: Apoptosis in lymphoid and parenchymal cells during sepsis: Findings in normal and T- and B-cell-deficient mice. Crit Care Med 1997; 25:1298-1307
25. 25. Borutaité V, Brown GC: Rapid reduction of nitric oxide by mitochondria, and reversible inhibition of mitochondrial respiration by nitric oxide. Biochem J 1996; 315(Pt 1):295-299
26. 26. Schweizer M, Richter C: Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 1994; 204:169-175
27. 27. Szabó C, Zingarelli B, O'Connor M, et al: DNA strand breakage, activation of poly (ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad Sci U S A 1996; 93:1753-1758
28. 28. Zingarelli B, O'Connor M, Wong H, et al: Peroxynitrite-mediated DNA strand breakage activates poly-adenosine diphosphate ribosyl synthetase and causes cellular energy depletion in macrophages stimulated with bacterial lipopolysaccharide. J Immunol 1996; 156:350-358
29. 29. Clementi E, Brown GC, Feelisch M, et al: Persistent inhibition of cell respiration by nitric oxide: Crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 1998; 95:7631-7636
30. 30. Lizasoain I, Moro MA, Knowles RG, et al: Nitric oxide and peroxynitrite exert distinct effects on mitochondrial respiration which are differentially blocked by glutathione or glucose. Biochem J 1996; 314(Pt 3):877-880
31. 31. Giardino I, Fard AK, Hatchell DL, et al: Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 1998; 47: 1114-1120
32. 32. Yildiz G, Demiryurek AT, Sahin-Erdemli I, et al: Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Phamacol 1998; 124:905-910
33. 33. Edelstein D, Brownlee M: Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 1992; 41:26-29
34. 34. Mikawa K, Nishina K, Tamada M, et al: Aminoguanidine attenuates endotoxin-induced acute lung injury in rabbits. Crit Care Med 1998; 26:905-911
35. 35. Ferrari R, Ferrari F, Benigno M, et al: Hibernating myocardium: Its pathophysiology and clinical role. Mol Cell Biochem 1998; 186(1-2):195-199
36. 36. Rosser DM, Stidwill RP, Jacobson D, et al: Oxygen tension in the bladder epithelium rises in both high and low cardiac output endotoxemic sepsis. J Appl Physiol 1995; 79: 1878-1882
37. 37. Boekstegers P, Weidenhofer S, Pilz G, et al: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991; 19: 317-323
38. 38. Boekstegers P, Weidenhofer S, Kapsner T, et al: Skeletal muscle partial pressure of oxygen in patients with sepsis. Crit Care Med 1994; 22:640-650
39. 39. Fink M: Cytopathic hypoxia in sepsis. Acta Anaesthesiol Scand Suppl 1997; 110: 87-95
40. 40. Gattinoni L, Brazzi L, Pelosi P, et al: A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group N Engl J Med 1995; 333:1025-1032
41. 41. Tuchschmidt J, Fried J, Astiz M, et al: Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102:216-220
42. 42. Hayes MA, Timmins AC, Yau EH, et al: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330:1717-1722